October 9 - Jason Pressley Lectureship | Dr. Manji  

Department of Psychiatry and Behavioral Sciences | Grand Rounds Series

Husseini Manji, MD, FRCPC Global Head, Johnson & Johnson Science for Minds

Friday, October 9, 2020 | 12:00 p.m. - 1:00 p.m.

Live via WebEx | For more info email psych-events@musc.edu


13th Annual Jason Pressley Visiting Professorship "CNS Drug Discovery: Multiple Challenges, Multiple Opportunities"

The Department of Psychiatry and Behavioral Sciences hosts bimonthly Grand Rounds that span the academic year. Join us as we welcome Dr. Husseini Manji, MD, FRCP, Global Head, Johnson & Johnson Science to evaluate mankind’s most devastating illnesses. Indeed, in the United States alone this burden of illness is rapidly approaching $1 trillion annually, a number that is only likely to escalate in coming years. Moreover, mental illnesses are the "chronic diseases of the young", and a leading cause of disability. Their cost to society worldwide is higher than that of cancer, diabetes, and chronic respiratory diseases combined. This Grand Rounds presentation will discuss interrelated facets in our search to better understand the mechanisms underlying a wide range of mental illnesses and to develop effective new treatments for them. Rapid advances in science and technology over the past decade have provided us with an unprecedented opportunity and the tools needed to unlock the secrets of the brain. Although public and private resources devoted to research in this area are diminishing, a host of cutting-edge approaches— from genomics to data mining, proteomics to biomarkers, pathway modeling to protein engineering, neuroimaging to optogenetics—is nevertheless revolutionizing the way we think about, study, and approach the development of urgently needed and promising results. Join us to discuss promising areas for improved outcomes.

The Medical University of South Carolina designates this live activity for a maximum of 1.0 AMA PRA Category 1.0 Credit(s)™.

At the completion of the presentation, attendees will be able to:

1. Understand how targeting synaptic plasticity mechanisms is leading to development of completely novel, rapid-acting antidepressants.

2. Understand how mapping symptoms onto neuronal circuits can allow for the optimal treatment of discrete illness dimensions.

3. Describe how digital technology tools may aid in achieving optimal outcomes for patients.


To join the training session

Session number: 120 625 2259

Session password: 7Ru9JX

1. Go to https://musc.webex.com/musc/k2/j.php?MTID=ta37fbc1864d74a66ab8fea5d136fa0e9

2. Enter your name and email address.

3. Enter the session password: 7Ru9JX

4. Click "Join Now".

5. Follow the instructions that appear on your screen.